Newsletter

Ujjwal Maheshwari

Ujjwal Maheshwari is a Sydney-based financial writer at Stocks Down Under, where he has covered ASX and forex markets for over three years. He specialises in breaking down complex market developments into clear, accessible analysis for everyday investors.

Bachelor of Commerce (Finance), University of New South Wales (UNSW)

728 articles published

Energy Stocks

UAE Quits OPEC: Which ASX Energy Stocks Win And Lose?

ASX Energy Stocks Hit by UAE OPEC Exit The United Arab Emirates announced this week that it will leave OPEC on 1 May 2026, ending nearly 60 years of membership. The UAE was OPEC's third-biggest producer after Saudi Arabia and Iraq. It will also leave the wider OPEC+ group. The news shocked global oil markets…

ByUjjwal MaheshwariApril 30, 20260Comments

Mining Stocks

Tivan (ASX:TVN) Jumps 8% on Molyhil Scoping Study, Decades-Long Tungsten Mine Takes Shape

Tivan Rises on Molyhil Tungsten Mine Study Tivan (ASX:TVN) jumped 8% on Wednesday after returning from a trading halt with the long-awaited scoping study for its Molyhil tungsten and molybdenum project in the Northern Territory. The move builds on a remarkable run, with the stock up roughly 20% so far in 2026 and more than…

ByUjjwal MaheshwariApril 30, 20260Comments

Gold Stocks

Ramelius Resources (ASX:RMS) Reports Record 62% AISC Margin- So Why Did the Stock Slip?

Ramelius Reports Record Margin But Stock Slips Ramelius Resources (ASX:RMS) had a confusing day on the market yesterday. The Western Australian gold miner just delivered the most profitable quarter in its history, yet the share price closed 2.18% lower at A$3.59. For investors, the natural question is simple: if the business is doing this well,…

ByUjjwal MaheshwariApril 30, 20260Comments

Biotech Stocks

Syntara (ASX:SNT) Returns to Trading After A$10m Raise and FDA Green Light: What It Means for Investors

Syntara Returns After A$10m Raise and FDA Win Syntara (ASX:SNT) resumed trading yesterday with two pieces of good news in the same week: A$10 million in fresh capital and a thumbs-up from the US FDA on its next big trial for amsulostat (formerly SNT-5505), the company's lead drug. Shares slipped 12.5% to A$0.028, suggesting some…

ByUjjwal MaheshwariApril 30, 20260Comments

Bank Stocks

Australia CPI 4.6%, Trimmed Mean 3.3%: Is The RBA Rate Hike Still Coming?

CPI hit 4.6%. But the trimmed mean held at 3.3% Australia's headline inflation jumped to 4.6% in the year to March 2026, the highest level since September 2023. The Australian Bureau of Statistics released the data this morning, showing inflation accelerated sharply from February's 3.7% reading. On a quarterly basis, annual CPI accelerated to 4.1%…

ByUjjwal MaheshwariApril 29, 20260Comments

ASX small caps that could rebound after EOFY tax-loss selling

Bank Stocks Market news

Will the RBA Hike To 4.35% On May 5? Today’s CPI Number Decides

RBA May Hike Again if CPI Runs Hot The Australian Bureau of Statistics releases the March quarter inflation number at 11:30 am today, and it decides whether the Reserve Bank hikes the cash rate from 4.10% to 4.35% on 5 May. All four big four banks (CBA, NAB, Westpac and ANZ) are now forecasting a…

ByUjjwal MaheshwariApril 29, 20260Comments

Gold Stocks Mining Stocks

Capricorn Metals (ASX:CMM) Slides Despite 31% Mt Gibson Resource Upgrade to 895,000 Ounces

Capricorn Metals Falls Despite Mt Gibson Gold Upgrade Capricorn Metals (ASX:CMM) has been under pressure recently, even after delivering one of its biggest pieces of good news this year. The mid-tier gold producer just lifted its Orion South underground resource at Mt Gibson by 31% to 895,000 ounces, and yesterday's Lexington update confirmed a 900-metre…

ByUjjwal MaheshwariApril 29, 20260Comments

Defence Stocks

Is It Too Late To Buy Elsight (ASX:ELS)? Stock Up 1,600% On U.S. Defence Blue List Win

Elsight Stock Soars on U.S. Defence Win Elsight (ASX:ELS) closed up 4.3% today at A$6.99, after touching a new all-time intraday high of A$7.33 on news that the company has won one of the most important defence approvals on the ASX. The company's flagship Halo connectivity platform has been included on the U.S. Department of…

ByUjjwal MaheshwariApril 28, 20260Comments

Technology Tech Stocks

Megaport (ASX:MP1) Jumps 9% on Major AI Contract: Is the Comeback Finally Here?

Megaport Lands Major AI Infrastructure Contract Megaport (ASX:MP1) shares touched A$9.73 during a 9% intraday rally on Monday before closing up 5% at A$9.34 after the company landed a major new contract through its Latitude.sh business. The three-year deal is worth A$35.4m and comes from a fast-growing US tech company that builds tools for enterprise…

ByUjjwal MaheshwariApril 28, 20260Comments

Resources

IperionX (ASX:IPX) Climbs 4.7% as Virginia Goes 24/7 and GenX Targets 2026 Validation

IperionX Rises as Virginia Plant Goes 24/7 IperionX (ASX:IPX) rose 4.66% to A$4.27 on Monday after the company's March 2026 quarterly report confirmed its Virginia titanium plant is now running 24 hours a day, seven days a week. Production is still in early ramp-up mode, but management is targeting a run-rate of 200 tonnes per…

ByUjjwal MaheshwariApril 27, 20260Comments

the Kick-ass Multipurpose WordPress Theme

Ujjwal Maheshwari

UAE Quits OPEC: Which ASX Energy Stocks Win And Lose?

Tivan (ASX:TVN) Jumps 8% on Molyhil Scoping Study, Decades-Long Tungsten Mine Takes Shape

Ramelius Resources (ASX:RMS) Reports Record 62% AISC Margin- So Why Did the Stock Slip?

Syntara (ASX:SNT) Returns to Trading After A$10m Raise and FDA Green Light: What It Means for Investors

Australia CPI 4.6%, Trimmed Mean 3.3%: Is The RBA Rate Hike Still Coming?

Will the RBA Hike To 4.35% On May 5? Today’s CPI Number Decides

Capricorn Metals (ASX:CMM) Slides Despite 31% Mt Gibson Resource Upgrade to 895,000 Ounces

Is It Too Late To Buy Elsight (ASX:ELS)? Stock Up 1,600% On U.S. Defence Blue List Win

Megaport (ASX:MP1) Jumps 9% on Major AI Contract: Is the Comeback Finally Here?

IperionX (ASX:IPX) Climbs 4.7% as Virginia Goes 24/7 and GenX Targets 2026 Validation

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Ujjwal Maheshwari

Stocks in Spotlight

Add Your Heading Text Here